E.I.D. Parry (India) Limited has announced its unaudited financial results for the quarter and half-year ended September 30, 2025. The Board of Directors approved these results on November 11, 2025, following a review by the Audit Committee. These results reflect the company’s performance across various segments including Sugar, Co-generation, and Nutraceuticals. The company continues to implement strategic initiatives to improve cost efficiencies and drive growth.
Financial Highlights
E.I.D. Parry (India) Limited’s Board of Directors approved the unaudited standalone and consolidated financial results for Q2 2026 (Jul-Sep) and H1 FY2026 (Apr-Sep) in a meeting held on November 11, 2025.
Standalone Performance
Standalone revenue from operations for the quarter ended September 30, 2025, stood at ₹754 Crore. Earnings before interest, tax, depreciation, and amortization (EBITDA) for the quarter were ₹155 Crore (excluding exceptional items). The standalone loss after tax for the quarter was ₹285 Crore. For H1 FY2026, standalone revenue from operations was ₹1,513 Crore, and EBITDA was ₹168 Crore (excluding exceptional items). The standalone loss after tax was ₹313 Crore.
Consolidated Performance
Consolidated revenue from operations for the quarter ended September 30, 2025, reached ₹11,624 Crore, an increase of 24% compared to the previous year. Earnings before interest, tax, depreciation, and amortization (EBITDA) for the quarter were ₹1,349 Crore, an increase of 31% year-over-year. The consolidated profit after tax and non-controlling interest was ₹424 Crore. For the half-year ended September 30, 2025, consolidated revenue from operations was ₹20,348 Crore, an increase of 27%. EBITDA for the half-year was ₹2,244 Crore, an increase of 44%. The consolidated profit after tax and non-controlling interest was ₹671 Crore.
Segmental Performance
Sugar Division: Reported a Loss before Interest and Tax of ₹(14) Crore for the quarter.
Farm Inputs Division: Reported a Profit before Interest and Tax of ₹1,129 Crore for the quarter.
Nutraceuticals Division: Registered a profit before Interest and Tax of ₹23 Crore for the quarter.
Source: BSE
